ORIGINAL RESEARCH article
Front. Immunol.
Sec. Viral Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1613034
This article is part of the Research TopicLong- and Post-COVID Syndromes: Immune Mechanisms and Therapeutic StrategiesView all 3 articles
Dysregulated monocyte compartment in PACS patients
Provisionally accepted- 1Laboratory for Experimental Transfusion Medicine, Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden; Dresden, Germany, Dresden, Germany
- 2Institute for Transfusion Medicine Dresden, DRK Blood Donation Service North-East, Dresden, Lower Saxony, Germany
- 3Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany
- 4Department of Pneumology, Medical Clinic I, University Hospital Carl Gustav Carus, Dresden, Lower Saxony, Germany
- 5Department of Transfusion Medicine, Medical Clinic I, University Hospital Carl Gustav Carus, Dresden, Lower Saxony, Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
1-5% of all patients with COVID-19, a disease caused by infection with Severe Acute Respiratory Syndrome Virus 2 (SARS-Cov-2), even those with mild COVID-19 symptoms, continue to have symptoms after initial recovery. Symptoms associated with the post-acute sequelae of COVID-19 (PACS) include, among others, fatigue, shortness of breath, cough, and cognitive dysfunction. Since the dysregulated immune response appears to be caused by the sustained activation of certain immune cells, including monocytes, and the release of specific cytokines, the aim of our study was to investigate the effect of PACS disease on monocyte subpopulations. Twenty-two healthy and thirty-two patients with PACS were included into this study. We performed blood gas analysis and measured hematological parameters from peripheral blood of PACS patients and compared them with healthy donors. Surface markers to identify monocyte subpopulations were analyzed by flow cytometry. PACS patients had higher numbers of intermediate and CD56+ monocytes, whereas the numbers of total monocytes, classical and non-classical monocytes were normal compared to healthy donors. Comparison of patients with and without fatigue, cough, and dyspnea showed no difference in monocyte subset frequencies. However, patients with cognitive dysfunction had increased numbers of non-classical monocytes compared to patients without this symptom. This suggests a disturbed homeostasis of the monocyte subsets in the peripheral blood of patients with PACS.
Keywords: Monocytes, intermediate monocytes, CD56+ monocytes, COVID-19, PACS, SARS-CoV-2
Received: 16 Apr 2025; Accepted: 15 May 2025.
Copyright: © 2025 Kronstein-Wiedemann, Teichert, Michel, Berg, Robinson, Tausche, Kolditz, Bergleiter, Thiel, Koschel, Künzel, Hölig, Tonn and Rossol. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Romy Kronstein-Wiedemann, Laboratory for Experimental Transfusion Medicine, Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden; Dresden, Germany, Dresden, Germany
Manuela Rossol, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.